Re-ref Com On Appropriations/Base Budget
Email me when SB 1018 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track SB 1018. By continuing you agree to the Terms and Privacy Policy.
Legislative status
- Introduced
- In Committee
- Reported by Committee
- Floor Vote Scheduled
- Passed One Chamber
- Passed Both Chambers
- Sent to Executive
- Signed into Law
Summary
The HEAL Act establishes the Breakthrough Therapies Research (BTR) Grant Fund within the Department of Health and Human Services to provide up to five $1 million grants for three‑year studies on psychedelic drugs such as ibogaine, MDMA, and psilocybin. Eligible applicants are federal or academic research entities in North Carolina that will study veterans, first responders, frontline health workers, or survivors of domestic violence/sexual assault. A new task force will oversee the grant process, evaluate findings, and advise on future licensing and insurance rules.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about SB 1018
3 free questions a day, no accountHistory
- Withdrawn From Com
- Re-ref Com On Appropriations/Base Budget
- Ref To Com On Rules and Operations of the Senate
- Passed 1st Reading
- Filed
Sponsors
- Sophia Chitlik (D) · sponsor
- Brinson
- Chitlik
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when SB 1018 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track SB 1018 freeOr ask your AI assistant about SB 1018 directly:
Add to Claude, ChatGPT or Cursor